1. Home
  2. CBAN vs PEPG Comparison

CBAN vs PEPG Comparison

Compare CBAN & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$17.40

Market Cap

282.0M

Sector

Finance

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.59

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
PEPG
Founded
1975
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.0M
317.6M
IPO Year
1998
2022

Fundamental Metrics

Financial Performance
Metric
CBAN
PEPG
Price
$17.40
$5.59
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.50
AVG Volume (30 Days)
62.2K
839.5K
Earning Date
01-21-2026
11-12-2025
Dividend Yield
2.63%
N/A
EPS Growth
26.78
N/A
EPS
1.59
N/A
Revenue
$122,550,000.00
N/A
Revenue This Year
$20.97
N/A
Revenue Next Year
$25.65
N/A
P/E Ratio
$10.99
N/A
Revenue Growth
12.48
N/A
52 Week Low
$13.99
$0.88
52 Week High
$18.41
$6.72

Technical Indicators

Market Signals
Indicator
CBAN
PEPG
Relative Strength Index (RSI) 61.87 55.10
Support Level $17.00 $5.04
Resistance Level $17.70 $6.72
Average True Range (ATR) 0.36 0.57
MACD 0.09 -0.06
Stochastic Oscillator 82.25 34.91

Price Performance

Historical Comparison
CBAN
PEPG

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: